Orladeyo Now Approved in Saudi Arabia to Prevent HAE Attacks | Regulators OK Oral, Once-daily Therapy for HAE Patients 12 and Older
Regulatory authorities in Saudi Arabia have authorized day by day Orladeyo (berotralstat) to forestall hereditary angioedema (HAE) assaults in grownup ...